回复v2784035发表于：2020/9/17 20:44:54悬赏金额：
12积分 状态：
未解决
Treatment of nonresectable hepatocellular carcinoma: review of the literature and meta-analysis
【作 者】Malaguarnera M;Trovato G;Restuccia S;Giugno I;Franzé CM;Receputo G;Siciliano R;Motta M;Trovato BA.
【刊 名】Advances in therapy
【出版日期】1994
【卷 号】Vol.11
【期 号】No.6
【页 码】303-319
Usefulness of hepatic arterial infusion chemotherapy using lecithin-added lipiodol emulsion in hepatocellular carcinoma 【作 者】Kobayashi S;Koizumi S;Katagiri S;Ariizumi S;Takahashi Y;Otsubo T;Takasaki K;Yamamoto M.
【刊 名】Gan To Kagaku Ryoho
【出版日期】2007
【卷 号】Vol.34
【期 号】No.9
【页 码】1433-1437
Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of two kinds of dosages of anticancer drugs and analysis of prognostic factors 【作 者】Lu W;Li Y;He X;Chen Y.
【刊 名】Hepatogastroenterology
【出版日期】2003
【卷 号】Vol.50
【期 号】No.54
【页 码】2079-2083
谢谢
您现在的位置：
